Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * FURMAN JOHN B	2. Issuer Name and Ticker or Trading Symbol SMITH & WESSON BRANDS, INC. [ AOBC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) 2100 ROOSEVELT AVENUE	3. Date of Earliest Transaction (MM/DD/YYYY) 5/28/2020
(Street) SPRINGFIELD, MA 01104 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	5/28/2020		M		10000	A	$2.65	52790	D
Common Stock	5/28/2020		M		10000	A	$3.69	62790	D
Common Stock	5/28/2020		S(1)		20000	D	$10.75	42790	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (Right to Buy)	$2.65	5/28/2020		M			10000	(2)	9/26/2021	Common Stock	10000	$0.00	0	D
Director Stock Option (Right to Buy)	$3.69	5/28/2020		M			10000	(3)	9/27/2020	Common Stock	10000	$0.00	0	D

Explanation of Responses:
(1)	The shares were sold pursuant to a 10b5-1 Trading Plan dated December 10, 2019.
(2)	1/12th of the total number of options granted vested and became exercisable each month after the September 26, 2011 date of grant, until fully vested on September 26, 2012.
(3)	1/12th of the total number of options granted vested and became exercisable each month after the September 27, 2010 date of grant, until fully vested on September 27, 2011.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
FURMAN JOHN B 2100 ROOSEVELT AVENUE SPRINGFIELD, MA 01104	X

Signatures
/s/ Robert J. Cicero, as attorney-in-fact		5/29/2020
**Signature of Reporting Person		Date